Index Entries

1567 Results
TitleIS Publication Date
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell LineFebruary 25, 2022
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, FranceNovember 30, 2020
Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case SeriesJune 22, 2022
Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse modelAugust 18, 2021
Investigating the current status of COVID-19 related plastics and their potential impact on human healthAugust 13, 2021
Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccinationJuly 15, 2022
Investigation of metallic contaminations found in vector- and mRNA-based COVID-19-”vaccines”: Preliminary ResultsMarch 20, 2022
Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?April 20, 2021
Is FDA ‘Covering for Pfizer’? Court Orders Agency to Release a Million More Pages of COVID Vaccine DocumentsDecember 9, 2024
Is the US’s Vaccine Adverse Event Reporting System broken?November 10, 2023
Is there a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality?February 21, 2023
It’s time to withdraw the mRNA vaccinesJanuary 9, 2023
Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical TrialApril 30, 2024
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort StudyAugust 26, 2021
Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational StudyDecember 15, 2020
Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases EvaluationDecember 2020
Ivermectin Could Have Saved Millions of Lives, Why Was It SuppressedJune 20, 2023
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2August 31, 2020
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomesFebruary 29, 2024
Ivermectin for COVID-19: Real-time meta-analysis of 99 studiesNovember 26, 2020
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical GuidelinesJuly / August 2021
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trialMay 13, 2021
Ivermectin prophylaxis used for COVID-19 reduces COVID-19 infection and mortality rates: A 220,517-subject, populational-level retrospective citywide observational studyJanuary 2022
Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score MatchingJanuary 15, 2022
Ivermectin reduces in vivo coronavirus infection in a mouse experimental modelMarch 30, 2021
Ivermectin: A Drug Worthy of a Nobel Prize, but Inaccessible for Those Who Need ItOctober 25, 2015
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19August 3, 2021
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimenJune 12, 2020
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19October 7, 2020
Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectationsFebruary 15, 2017
Ivermectin: Provide partial monitoring results in expanded use in positive patientsJune 9, 2021
Japanese Professor Upends Ministry of Health: Disband Vax Committee, Investigate All InjuriesDecember 1, 2022
Jeffrey Sachs on COVID-19 – “I’m pretty convinced it came out of US lab biotechnology"June 2022
Johnson & Johnson clinical trial: A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult ParticipantsFirst posted August 10, 2020; last update May 6, 2023
Kansas AG sues Pfizer for misleading Kansans on COVID vaccineJune 17, 2024
Kids and Speech DelaysJanuary 26, 2022
King County, WA: COVID-19 Outcomes by Vaccination Status
Kolaviron (Kolaflavanone), apigenin, fisetin as potential Coronavirus inhibitors: In silico investigationAugust 4, 2020
Kounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and managementJune 19, 2024
Laboratory testing for coronavirus disease (COVID-19) in suspected human casesMarch 19, 2020
Lack of correlation between school mask mandates and paediatric COVID-19 cases in a large cohortNovember 29, 2022
Large-scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 InfectionDecember 31, 2021
Lasting immunity found after recovery from COVID-19January 26, 2021
Latest statistics on England mortality data suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of Covid-19 vaccinationDecember 3, 2021
Legal Letter on Behalf of Physicians Regarding Covid-19 Vaccine Injuries (to heads of the DHHS, CDC, and FDA)October 27, 2021
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)February 22, 2021
Letter from a Los Angeles Psychiatrist to his PatientsFebruary 2022
Letter from Ron Johnson to HHS, FDA and CDC directing them to preserve all records relating to COVID-19 vaccinesNovember 19, 2024
Letter from Senator Ron Johnson to Lloyd J. Austin III, Secretary of the Department of DefenseFebruary 1, 2022
Letter from US Senators to USAID regarding funding and activities of EcoHealth AllianceSeptember 14, 2022